138 results
424B3
ADIL
Adial Pharmaceuticals Inc
23 Apr 24
Prospectus supplement
4:00pm
”). Neither we nor any Selling Stockholders takes any responsibility for, or provides any assurance as to the reliability of, any information other than … operations from the development of its new business opportunities. There can be no assurance that we will be successful in accomplishing these objectives
424B5
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Prospectus supplement for primary offering
5:31pm
business opportunities. There can be no assurance that we will be successful in accomplishing these objectives. Without such additional capital, we may … than the price per share paid by investors in this offering. No assurance can be given as to our ability to procure additional financing, if required
8-K
EX-1.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
this Section 2(b) on the Trading Market at the time of sale of such Shares.
(ii) The Company acknowledges and agrees that (A) there can be no assurance … to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
8-K
EX-5.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.
Based on the foregoing, and subject
424B3
wlzwnpdk9th99
20 Nov 23
Prospectus supplement
7:46am
8-K
EX-10.1
go3ya9brse2n2451i
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-99.1
rjv izu1q
26 Sep 23
Other Events
9:08pm